Biomarker-driven treatment for muscle-invasive bladder cancer (MIBC) led to a 2-year metastasis-free survival (MFS) rate that ...

While several molecular markers that are used to evaluate the development and prognosis of bladder cancer have been studied, the limited value of these established markers has created the need for ...

The research team designed a new diagnostic kit that detects bladder cancer biomarkers by utilizing the principle of layering ...

(UroToday.com) The 2024 Society of Urologic Oncology (SUO) annual meeting held in Dallas, between December 3 and December 6, ...

Bladder cancer ranks as the 10th most commonly diagnosed cancer globally, affecting both men and women. Approximately 75% of patients are initially diagnosed with non-muscle invasive bladder cancer ...

Cell-free DNA (cfDNA) is one of the important biomarkers of liquid biopsy for many malignant cancers like urothelial bladder cancer. However, the use of cfDNA in upper tract urothelial carcinoma ...

The bladder cancer detection kit market is growing rapidly, driven by innovations like AI integration, biomarker-based tests, and non-invasive solutions.Austin, Dec. 12, 2024 (GLOBE NEWSWIRE) -- ...

An experimental immunotherapy drug is a potentially effective treatment for patients with bladder cancer who no longer ...

Recent research bolsters the case that radiotherapy to treat primary endometrial cancer is associated with an increased risk ...

Bladder cancer affects the body’s ability to urinate and can inflict pain. Healthcare professionals understand what causes this disease, though researchers are finding new causes. What are the latest ...

Bladder cancer is one of the most common types of cancer, particularly among older adults. While genetics and age play a role, lifestyle factors can significantly impact your risk. Making natural, ...